Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: A pilot study on differential effects of sex hormones on antidepressant effects

Chi Un Pae, Laura Mandelli, Tae Suk Kim, Changsu Han, Prakash S. Masand, David M. Marks, Ashwin A. Patkar, David C. Steffens, Diana De Ronchi, Alessandro Serretti

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The incidence or recurrence of major depression is greatly increased in women during the transition to and after menopause and hormonal changes occurring during these periods are thought to play an important role in depressive recurrence. It has been also suggested that a chronic hypoestrogenic state may reduce the response to antidepressant drugs, but whether or not, and the extent to which hormonal changes related to menopause influence the response to antidepressant drugs, is yet to be determined. Thirty-nine female patients (n = 17 in pre-menopause; n = 22 in post-menopause) with major depressive disorder (MDD) based on DSM-IV criteria, who were not on hormonal replacement therapy, participated in the study in order to prospectively evaluate the effect of menopausal status and its hormonal correlates on the effectiveness of antidepressant treatment for 6 weeks. The Hamilton Depression Rating Scale-17 item (HAMD), the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Clinical Global Impression Severity scale (CGI-S) were administered at baseline, week 1, week 3, and week 6. The CGI-I scale was also assessed at weeks 1, 3, and 6. After controlling for age, age at onset, baseline symptom severity, antidepressant dosage and hormonal levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2), post-menopausal women showed a poor response to antidepressants over 6 weeks of treatment, compared to the response of pre-menopausal women. Old age and high levels of FSH were also associated with the efficacy of antidepressants in post-menopausal women. In conclusion, sex hormones are known to interact with serotonergic, noradrenergic and dopaminergic systems. Despite methodological limitations, our study suggests that menopausal status and old age are predictors of a poor response to antidepressant treatment. Furthermore, the FSH may interfere with the mechanism of action of the antidepressant agents. Hence, larger, randomized and controlled trials are warranted to expand our understanding of this area.

Original languageEnglish
Pages (from-to)228-235
Number of pages8
JournalBiomedicine and Pharmacotherapy
Volume63
Issue number3
DOIs
Publication statusPublished - 2009 Mar 1

Fingerprint

Gonadal Steroid Hormones
Antidepressive Agents
Follicle Stimulating Hormone
Depression
Menopause
Premenopause
Postmenopause
Recurrence
Major Depressive Disorder
Luteinizing Hormone
Age of Onset
Diagnostic and Statistical Manual of Mental Disorders
Estradiol
Therapeutics
Randomized Controlled Trials
Incidence

Keywords

  • Antidepressant
  • Depression
  • Menopause
  • Mood disorders

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women : A pilot study on differential effects of sex hormones on antidepressant effects. / Pae, Chi Un; Mandelli, Laura; Kim, Tae Suk; Han, Changsu; Masand, Prakash S.; Marks, David M.; Patkar, Ashwin A.; Steffens, David C.; De Ronchi, Diana; Serretti, Alessandro.

In: Biomedicine and Pharmacotherapy, Vol. 63, No. 3, 01.03.2009, p. 228-235.

Research output: Contribution to journalArticle

Pae, Chi Un ; Mandelli, Laura ; Kim, Tae Suk ; Han, Changsu ; Masand, Prakash S. ; Marks, David M. ; Patkar, Ashwin A. ; Steffens, David C. ; De Ronchi, Diana ; Serretti, Alessandro. / Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women : A pilot study on differential effects of sex hormones on antidepressant effects. In: Biomedicine and Pharmacotherapy. 2009 ; Vol. 63, No. 3. pp. 228-235.
@article{c55a0293b3c0432287d560b832469c0b,
title = "Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: A pilot study on differential effects of sex hormones on antidepressant effects",
abstract = "The incidence or recurrence of major depression is greatly increased in women during the transition to and after menopause and hormonal changes occurring during these periods are thought to play an important role in depressive recurrence. It has been also suggested that a chronic hypoestrogenic state may reduce the response to antidepressant drugs, but whether or not, and the extent to which hormonal changes related to menopause influence the response to antidepressant drugs, is yet to be determined. Thirty-nine female patients (n = 17 in pre-menopause; n = 22 in post-menopause) with major depressive disorder (MDD) based on DSM-IV criteria, who were not on hormonal replacement therapy, participated in the study in order to prospectively evaluate the effect of menopausal status and its hormonal correlates on the effectiveness of antidepressant treatment for 6 weeks. The Hamilton Depression Rating Scale-17 item (HAMD), the Montgomery-{\AA}sberg Depression Rating Scale (MADRS) and the Clinical Global Impression Severity scale (CGI-S) were administered at baseline, week 1, week 3, and week 6. The CGI-I scale was also assessed at weeks 1, 3, and 6. After controlling for age, age at onset, baseline symptom severity, antidepressant dosage and hormonal levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2), post-menopausal women showed a poor response to antidepressants over 6 weeks of treatment, compared to the response of pre-menopausal women. Old age and high levels of FSH were also associated with the efficacy of antidepressants in post-menopausal women. In conclusion, sex hormones are known to interact with serotonergic, noradrenergic and dopaminergic systems. Despite methodological limitations, our study suggests that menopausal status and old age are predictors of a poor response to antidepressant treatment. Furthermore, the FSH may interfere with the mechanism of action of the antidepressant agents. Hence, larger, randomized and controlled trials are warranted to expand our understanding of this area.",
keywords = "Antidepressant, Depression, Menopause, Mood disorders",
author = "Pae, {Chi Un} and Laura Mandelli and Kim, {Tae Suk} and Changsu Han and Masand, {Prakash S.} and Marks, {David M.} and Patkar, {Ashwin A.} and Steffens, {David C.} and {De Ronchi}, Diana and Alessandro Serretti",
year = "2009",
month = "3",
day = "1",
doi = "10.1016/j.biopha.2008.03.010",
language = "English",
volume = "63",
pages = "228--235",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "3",

}

TY - JOUR

T1 - Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women

T2 - A pilot study on differential effects of sex hormones on antidepressant effects

AU - Pae, Chi Un

AU - Mandelli, Laura

AU - Kim, Tae Suk

AU - Han, Changsu

AU - Masand, Prakash S.

AU - Marks, David M.

AU - Patkar, Ashwin A.

AU - Steffens, David C.

AU - De Ronchi, Diana

AU - Serretti, Alessandro

PY - 2009/3/1

Y1 - 2009/3/1

N2 - The incidence or recurrence of major depression is greatly increased in women during the transition to and after menopause and hormonal changes occurring during these periods are thought to play an important role in depressive recurrence. It has been also suggested that a chronic hypoestrogenic state may reduce the response to antidepressant drugs, but whether or not, and the extent to which hormonal changes related to menopause influence the response to antidepressant drugs, is yet to be determined. Thirty-nine female patients (n = 17 in pre-menopause; n = 22 in post-menopause) with major depressive disorder (MDD) based on DSM-IV criteria, who were not on hormonal replacement therapy, participated in the study in order to prospectively evaluate the effect of menopausal status and its hormonal correlates on the effectiveness of antidepressant treatment for 6 weeks. The Hamilton Depression Rating Scale-17 item (HAMD), the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Clinical Global Impression Severity scale (CGI-S) were administered at baseline, week 1, week 3, and week 6. The CGI-I scale was also assessed at weeks 1, 3, and 6. After controlling for age, age at onset, baseline symptom severity, antidepressant dosage and hormonal levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2), post-menopausal women showed a poor response to antidepressants over 6 weeks of treatment, compared to the response of pre-menopausal women. Old age and high levels of FSH were also associated with the efficacy of antidepressants in post-menopausal women. In conclusion, sex hormones are known to interact with serotonergic, noradrenergic and dopaminergic systems. Despite methodological limitations, our study suggests that menopausal status and old age are predictors of a poor response to antidepressant treatment. Furthermore, the FSH may interfere with the mechanism of action of the antidepressant agents. Hence, larger, randomized and controlled trials are warranted to expand our understanding of this area.

AB - The incidence or recurrence of major depression is greatly increased in women during the transition to and after menopause and hormonal changes occurring during these periods are thought to play an important role in depressive recurrence. It has been also suggested that a chronic hypoestrogenic state may reduce the response to antidepressant drugs, but whether or not, and the extent to which hormonal changes related to menopause influence the response to antidepressant drugs, is yet to be determined. Thirty-nine female patients (n = 17 in pre-menopause; n = 22 in post-menopause) with major depressive disorder (MDD) based on DSM-IV criteria, who were not on hormonal replacement therapy, participated in the study in order to prospectively evaluate the effect of menopausal status and its hormonal correlates on the effectiveness of antidepressant treatment for 6 weeks. The Hamilton Depression Rating Scale-17 item (HAMD), the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Clinical Global Impression Severity scale (CGI-S) were administered at baseline, week 1, week 3, and week 6. The CGI-I scale was also assessed at weeks 1, 3, and 6. After controlling for age, age at onset, baseline symptom severity, antidepressant dosage and hormonal levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2), post-menopausal women showed a poor response to antidepressants over 6 weeks of treatment, compared to the response of pre-menopausal women. Old age and high levels of FSH were also associated with the efficacy of antidepressants in post-menopausal women. In conclusion, sex hormones are known to interact with serotonergic, noradrenergic and dopaminergic systems. Despite methodological limitations, our study suggests that menopausal status and old age are predictors of a poor response to antidepressant treatment. Furthermore, the FSH may interfere with the mechanism of action of the antidepressant agents. Hence, larger, randomized and controlled trials are warranted to expand our understanding of this area.

KW - Antidepressant

KW - Depression

KW - Menopause

KW - Mood disorders

UR - http://www.scopus.com/inward/record.url?scp=61349175827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349175827&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2008.03.010

DO - 10.1016/j.biopha.2008.03.010

M3 - Article

C2 - 18502089

AN - SCOPUS:61349175827

VL - 63

SP - 228

EP - 235

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 3

ER -